advertisement

---

Sun Y 7

Showing records 1 to 7 | Display all abstracts from Sun Y

70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Sun Y
BMC Ophthalmology 2016; 16: 150

---

70800 Expression of erythropoietin in neovascular glaucoma and its role in the angiogenesis in vitro
Sun Y
Zhonghua Yi Xue Za Zhi 2016; 96: 3729-3734

---

70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Liang Y
BMC Ophthalmology 2016; 16: 150

---

70800 Expression of erythropoietin in neovascular glaucoma and its role in the angiogenesis in vitro
Xing YQ
Zhonghua Yi Xue Za Zhi 2016; 96: 3729-3734

---

70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Zhou P
BMC Ophthalmology 2016; 16: 150

---

70800 Expression of erythropoietin in neovascular glaucoma and its role in the angiogenesis in vitro
Guan WY
Zhonghua Yi Xue Za Zhi 2016; 96: 3729-3734

---

70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmology 2016; 16: 150

---